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A surprising set of recent observations suggests a link between assisted reproductive technology (ART) and epigenetic
errors—that is, errors involving information other than DNA sequence that is heritable during cell division. An
apparent association with ART was found in registries of children with Beckwith-Wiedemann syndrome, Angelman
syndrome, and retinoblastoma. Here, we review the epidemiology and molecular biology behind these studies and
those of relevant model systems, and we highlight the need for investigation of two major questions: (1) large-scale
case-control studies of ART outcomes, including long-term assessment of the incidence of birth defects and cancer,
and (2) investigation of the relationship between epigenetic errors in both offspring and parents, the speciﬁcmethods
of ART used, and the underlying infertility diagnoses. In addition, the components of proprietary commercial media
used in ART procedures must be fully and publicly disclosed, so that factors such as methionine content can be
assessed, given the relationship in animal studies between methionine exposure and epigenetic changes.
Introduction
The will to bear children is a categorical imperative for
many couples. In the United States alone, the drive to
overcome reproductive barriers has led to the develop-
ment of a multibillion-dollar medical industry that is
now supported by insurance laws in some states. Fur-
thermore, the United States Supreme Court (1977) has
ruled that the decision to bear children is constitutionally
protected, and thus, from a societal standpoint, assisted
reproductive technology (ART) differs from other areas
of medicine. Indeed, the practice of ART has evolved
largely outside the walls of academic medical research
institutions, although there are certainly outstanding ex-
ceptions to this rule. Nevertheless, this largely extra-
academic setting has consequences for ART research.
For example, although outcomes affecting the success of
pregnancy are closely studied, there has been a general
lack of measures of long-term outcomes affecting the
offspring themselves, related to the fact that ART and
obstetrics care are performed by different people, often
in different hospitals or cities. This history has important
implications for understanding the consequences of this
technology, and it is most important in any discussion
of reproduction and disease to be clear about how little
is known about these consequences. Recently, several
conﬂuent streams of evidence from human and animal
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studies have suggested that ART may lead to epigenetic
defects in the offspring—that is, genetic changes not in-
volving DNA sequence per se. The ﬁeld of epigenetics
is itself new, and our purpose in this review is to sum-
marize that evidence and to suggest what must be
learned in this scientiﬁcally intriguing—as well as emo-
tional, costly, and legally complex—area of medical
practice.
Birth Defects and ART
ART is deﬁned as those fertility treatments in which both
egg and sperm are manipulated in the laboratory (i.e.,
in vitro fertilization [IVF] and related procedures)
(Wright et al. 2003). Although the use of ART has be-
come a widely accepted and implemented therapy for
some forms of infertility, there have always been con-
cerns about the long-term safety of removing and han-
dling the germline. Some groups have studied short-term
outcomes of ART, consistently describing an increase in
multiple births and low birth weight (LBW) but not an
increase in major malformations (Wennerholm et al.
1991; Rufat et al. 1994; Saunders et al. 1996; Dhont et
al. 1997; D’Souza et al. 1997; Olivennes et al. 1997).
There are signiﬁcant limitations to these studies, how-
ever, involving either a small sample size, a short-term
period of follow-up, or a lack of matched controls. Re-
cent studies include those of Schieve et al. (2002), who
studied 42,000 offspring of ART, comparing them with
the rest of the U.S. population born in that year, and
found an increase in LBW, even in singletons. They did
not examine rates of birth defects in their sample. In a
small recent series, Place and Englert (2003) compared
66 children conceived by intracytoplasmic sperm injec-
600 Am. J. Hum. Genet. 74:599–609, 2004
tion (ICSI) with 52 conceived by IVF and 59 conceived
naturally, through the age of 5 years, and found no de-
velopmental differences. In a recent large series with a
control group from the same population, Hansen et al.
(2002) compared 1,138 offspring of ART in Australia
and also found LBW, as well as a twofold increase in
major birth defects. It is impossible to clearly stratify the
offspring with birth defects, given that the authors were
restricted by conﬁdentiality rules and could not indicate
the speciﬁc mode of conception for or the number of
birth defects in a given child. One case of Prader-Willi
syndrome was reported, when none would be expected
in a population of this size. Although the observation is
intriguing, statistical inferences cannot be made on only
one observation. Anthony et al. (2002) compared 4,224
IVF-conceived children with 314,000 naturally con-
ceived children in a Dutch national database, observing
a small (odds ratio 1.20) but statistically signiﬁcant in-
crease in malformations, including a signiﬁcant increase
in cardiovascular malformations. Given that birth
weight and Prader-Willi syndrome are both in part epi-
genetically controlled, an epigenetic connection seems
plausible for the increase in malformations seen in the
ART population.
Epigenetics and Human Genetic Disorders
Epigenetic alterations cause changes in gene expression
that are heritable during cell division and that do not
involve DNA sequence per se. These include DNAmeth-
ylation, a covalent modiﬁcation of cytosine at CpG din-
ucleotides, and chromatin modiﬁcations such as histone
acetylation, methylation, and phosphorylation. In gen-
eral, cytosine methylation and histone deacetylation are
associated with condensed chromatin states and silenced
gene expression. Genomic imprinting is an example of
epigenetic inheritance in eutherian mammals in which
differences in gene expression depend on the parental
origin of the allele. Imprinted genes frequently harbor
or lie near CpG islands or GC-rich sequences that have
differential methylation between the maternal and pa-
ternal alleles. Imprinting may involve strict monoallelic
expression but can occur with preferential but not ab-
solute expression of a speciﬁc parental allele, and im-
printing-directed gene expression is often tissue speciﬁc
(Lee et al. 1997). In addition, there is variation in im-
printing between individuals (Giannoukakis et al. 1996;
Sakatani et al. 2001) and familial aggregation of meth-
ylation patterns (Sandovici et al. 2003) at imprinted
genes.
Historically, epigenetics was of interest as the basis
of non-Mendelian inheritance of several phenomena in
model organisms that could not be explained by con-
ventional genetic variation, such as position effect var-
iegation in Drosophila melanogaster and telomere si-
lencing in yeast. However, in the past few years,
epigenetics has become central to our understanding of
normal mammalian development for several reasons.
First, normal embryogenesis cannot proceed without
the machinery of epigenetic regulation. Experiments in
mice show that knockouts of DNA methyltransferases
and histone modiﬁers are embryonic lethal (Li et al.
1992; Okano et al. 1999; Bourc’his et al. 2001; Peters
et al. 2001; Hata et al. 2002; Lagger et al. 2002). Ex-
periments in mice have show that an equal contribution
of both maternal and paternal chromosomes is required
for normal development (McGrath and Solter 1984;
Surani et al. 1984). Conceptuses with paternal disomy
have poor embryonic development with relatively nor-
mal development of the extraembryonic membranes,
whereas conceptuses with maternal disomy have poor
extraembryonic membrane development with relatively
less impaired embryonic development. In humans, em-
bryos possessing two paternal genomes form tropho-
blastic tumors, whereas embryos possessing two ma-
ternal genomes form teratomas. Second, a substantial
fraction of the human genome includes species-con-
served nonexonic elements that are rich in CpG dinu-
cleotides and are frequently the target of epigenetic
modiﬁcation (Elgar 1996; Hardison et al. 1997; On-
yango et al. 2000). Third, one of the principal lessons
of nuclear transfer cloning is that the information that
stably maintains a differentiated tissue-speciﬁc state in
a cell is, under the right conditions, reprogrammable
and therefore largely epigenetic. The genome of the new
pluripotent embryo is identical to the genome of the
differentiated somatic cell from which it was derived;
clearly, the information content, epigenetic by deﬁni-
tion, is altered in the new cellular environment of the
egg.
Epigenetic marks, including genomic imprinting, are
reprogrammed during normal gametogenesis (ﬁg. 1).
Primordial germ cells undergo demethylation as they
migrate along the genital ridge, both genomewide (Haj-
kova et al. 2002) and within imprinted loci (Hajkova
et al. 2002; Lee et al. 2002; Yamazaki et al. 2003).
Following this erasure, CpG methylation of imprinted
genes is reestablished during gametogenesis through de
novo methylation, in both eggs (Obata and Kono 2002)
and sperm (Davis et al. 2000; Ueda et al. 2000). After
fertilization, there is a phase of genomewide demethy-
lation that occurs in two stages. First, the male pro-
nucleus undergoes immediate active demethylation fol-
lowing fertilization (Mayer et al. 2000; Oswald et al.
2000); this is followed by passive demethylation of the
zygote genome (Howlett and Reik 1991; Rougier et al.
1998; Santos et al. 2002). However, methylation marks
on imprinted genes are protected from demethylation
(Tremblay et al. 1997; Shibata et al. 1998; Warnecke
et al. 1998), so that parental imprints are preserved.
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Figure 1 Dynamic reprogramming of the epigenome during development. Epigenetic marks, including DNA methylation and genomic
imprinting, are reprogrammed during normal gametogenesis. Primordial germ cells undergo epigenetic erasure as they migrate along the genital
ridge, and epigenetic marks are reestablished during gametogenesis, differentially in sperm (blue) and egg (pink). For example, after fertilization,
there is active demethylation of the paternal pronucleus, and then a second wave of passive demethylation of the zygote genome. Imprinted
genes (dotted line) are protected from this erasure. During development, tissue-speciﬁc epigenetic patterns emerge. The drawing is stylized, as
details are unknown.
After implantation, embryonic genomewide methyla-
tion patterns are established in a lineage-speciﬁc pattern
by de novo methylation (Rossant et al. 1986; Kafri et
al. 1992).
Birth weight appears to be in part epigenetically de-
termined. Studies of mice with engineered uniparental
disomy for a region of chromosome 11 show over-
growth where there is paternal duplication and growth
retardation where there is maternal duplication (Cat-
tanach and Kirk 1985). Many imprinted genes are
known to play important roles in determining fetal
growth (reviewed in Young 2001). For example, tar-
geted disruption in mouse of the imprinted Igf2 gene
results in progeny that are growth deﬁcient (DeChiara
et al. 1991), whereas overexpression by transgene ex-
pression (Sun et al. 1997) or loss of imprinting (Thor-
valdsen et al. 1998) results in overgrowth. These ob-
servations and others form the basis of the Haig
hypothesis, which proposes that genomic imprinting
evolved to balance the conﬂict between paternal evo-
lutionary drive to increase fetal growth and maternal
evolutionary drive to limit fetal size (Moore and Haig
1991).
Several human disorders involving birth defects have
now been shown to involve epigenetic alterations of
genomic imprinting. The cardinal features of Beckwith-
Wiedemann syndrome (BWS [MIM #130650]), which
is linked to a cluster of imprinted genes on 11p15.5,
are prenatal overgrowth, abdominal wall defects (om-
phalocele or umbilical hernia), neonatal hypoglycemia,
and macroglossia. Children with BWS are at an in-
creased risk of developing embryonal tumors, including
Wilms tumor and hepatoblastoma. Prader-Willi syn-
drome (MIM #176270), which is linked to a cluster of
imprinted genes on 15p11-13 normally expressed from
the paternal allele, is characterized by muscular hypo-
tonia, obesity, mental retardation, and hypogonado-
trophic hypogonadism. Another neurological birth
defect syndrome, Angelman syndrome (AS [MIM
#105830]), is also linked to 15p11-13—in this case, to
a gene normally expressed from the maternal allele (dis-
cussed in more detail below). The characteristic features
of AS include severe developmental delay, absent speech,
seizures, ataxia, hyperreﬂexia, and hypotonia.
Genetic mutations of the epigenetic machinery also
cause birth defects. Rett syndrome (MIM #312750) is
caused by mutations in the X-linked gene encoding
MECP2, a methyl-CpG-binding protein (Amir et al.
1999). MECP2 is thought to induce transcriptional si-
lencing by recruiting histone deacetylases to methylated
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Table 1
Summary of Studies of Epigenetic Disorders after ART






Molecularly ART Technique Reference
BWS:
4/6 LIT1 hypomethylation, 1/6
LIT1 hypomethylation, and
H19 hypermethylation NA 7 6 IVF and ICSI DeBaun et al. 2003
1/2 LIT1 hypomethylation 65 3 3 IVF and ICSI DeBaun et al. 2003
2/2 LIT1 hypomethylation 149 6 2 IVF and ICSI Maher et al. 2003
6/6 LIT1 hypomethylation 149 6 6 IVF and ICSI Gicquel et al. 2003
AS:
2/2 Sporadic imprinting defect at IC NA 2 2 ICSI Cox et al. 2002
Sporadic imprinting defect at IC NA 1 1 ICSI Orstavik et al. 2003
RB:
1/5 coding mutation in RB1 NA 5 5 IVF and ICSI Moll et al. 2003
NOTE.—NA p not available.
DNA; this hypothesis is supported by evidence that his-
tones are hyperacetylated in patients with Rett syn-
drome who have MECP2 mutations (Wan et al. 2001).
Immunodeﬁciency–centromeric instability–facial anom-
alies (ICF) syndrome (MIM #242860) is caused by re-
cessive mutations in the DNMT3B gene (Hansen et al.
1999; Xu et al. 1999), which encodes a DNA methyl-
transferase. Repeated sequences that are normally heav-
ily methylated in somatic cells are hypomethylated in
patients with ICF syndrome (Jeanpierre et al. 1993).
ICF syndrome is characterized by immunodeﬁciency in
association with facial dysmorphism and centromeric
instability of chromosomes 1, 9, and 16 in stimulated
cells. X-linked a-thalassemia–mental retardation syn-
drome (ATRX) (MIM #301040) is caused by mutations
in ATRX (Gibbons et al. 1995), which encodes a pu-
tative chromatin-remodeling protein. ATRX mutations
are associated with abnormalities in DNA methylation
in heterochromatic regions (Gibbons et al. 2000), sug-
gesting that ATRX regulates the repressed chroma-
tin state. Rubinstein-Taybi syndrome (RTS [MIM
#180849]) is caused by mutations of CREB-binding
protein (CBP) (Murata et al. 2001), a histone acetyl-
transferase. RTS is characterized by mental retardation,
short stature, and facial anomalies. CBP enhances tran-
scription of cAMP-responsive promoters by acetylating
histones in promoter nucleosomes (Ogryzko et al.
1996).
In addition, birth defects are often caused by uni-
parental disomy (UPD) for speciﬁc human chromo-
somes that harbor clusters of imprinted genes (reviewed
in Engel and DeLozier-Blanchet 1991). UPD occurs
when both homologues of a chromosome are inherited
from one parent, generating a diploid chromosome
number but an imbalance of maternally and paternally
inherited genes. It is thought that UPD can arise by a
number of mechanisms, including trisomy rescue, in
which a lethal trisomy is rescued by the loss of one
homologue (one-third of trisomy rescues would result
in UPD), and monosomy rescue, in which a lethal mon-
osomy is rescued by the duplication of the monosomic
chromosome. In addition, mosaicism for UPD can arise
by postzygotic somatic segregation errors (Robinson et
al. 2000). A phenotype associated with UPD necessarily
implicates an imprinted gene within that region.
Independently of congenital genetic syndromes, epi-
genetics plays a critical role in human cancer. Altera-
tions in DNA methylation, including hypomethylation
and hypermethylation, are linked to disrupted gene ex-
pression in a wide variety of tumors. Loss of imprinting
(LOI) is also common in both childhood and adult tu-
mors, and LOI in normal cells has been recently linked
to an increased personal and family history of colorectal
cancer (Cui et al. 2003). Of particular relevance to this
discussion, LOI can play a gatekeeper role in the de-
velopment of embryonal tumors of childhood, including
Wilms tumor of the kidney (reviewed by Feinberg and
Tycko [2004]).
BWS and ART
Recently, syndromes involving epigenetic alterations
have been reported to occur in individuals conceived
by ART techniques, including IVF and ICSI (table 1).
These include BWS, AS, and retinoblastoma (RB [MIM
#180200]). These disorders share a common etiology, in
that they can all involve epigenetic alterations, speciﬁ-
cally aberrant imprinting and/or DNA methylation.
BWS is associated with multiple distinct genetic and
epigenetic alterations of chromosomal band 11p15 that
involve the maternally inherited allele (reviewed in
DeBaun and Feinberg 2003). The imprinted gene region
on chromosome 11 includes two imprinted subdomains:
a more centromeric domain that includes p57KIP2,LIT1,
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TSSC3, and TSSC5 and a more telomeric subdomain
that includes IGF2 and H19 (Lee et al. 1999). About
5% of BWS cases involve conventional null mutations
in the maternal allele of p57KIP2, an imprinted mater-
nally expressed gene encoding a cyclin-dependent kinase
inhibitor. Another 15% of BWS cases involve imprint-
ing defects of the maternal alleles of the H19 and IGF2
genes. Here, the normally unmethylated maternal allele
is hypermethylated at a differentially methylated region
upstream of H19. As a result, the maternal allele of
H19 is silenced, whereas the maternal allele of IGF2 is
abnormally activated. This epigenetic alteration is as-
sociated speciﬁcally with increased cancer risk in pa-
tients with BWS (DeBaun et al. 2002). In addition,
∼40% of patients with BWS show LOI involving the
maternal copy of LIT1, an antisense RNA normally
expressed from the paternal allele (Lee et al. 1999; Smi-
linich et al. 1999). LOI of LIT1 in BWS involves acti-
vation of the normally silent maternal allele, likely caus-
ing epigenetic silencing of p57KIP2, because Lit1 appears
to mediate imprinting of p57KIP2 in a knockout mouse
model (Fitzpatrick et al. 2002) and in vitro experiments
(Horike et al. 2000). Loss of imprinting of LIT1 also
appears to be speciﬁcally associated with birth defects,
including prenatal overgrowth and midline abdominal
wall defects, such as omphalocele (DeBaun et al. 2002).
Approximately 10% of patients with BWS have pater-
nal uniparental disomy for the entire 11p15 region, in-
cluding H19, IGF2, LIT1, and p57KIP2.
DeBaun et al. (2003) identiﬁed seven children with
BWSwhowere born after use of ART.Molecular studies
of six of these children indicated that four had spon-
taneous imprinting defects involving the LIT1 subdo-
main, and one had imprinting defects at both the LIT1
and IGF2-H19 subdomains. In addition, DeBaun et al.
(2003) conducted a prospective analysis of the preva-
lence of ART in a series of patients with BWS, which
was 4.6% (3/65), compared with the population rate
of 0.76% in the same period in the United States. Sim-
ilarly, Maher et al. (2003) identiﬁed 6 patients with BWS
who were born after ART in a cohort of 149 sporadic
BWS births (4%). They compare this ﬁnding with a
background rate of 0.997% births after ICSI or IVF in
the United Kingdom.Molecular tests for UPDwere neg-
ative in all four cases tested, and they also found hy-
pomethylation of LIT1, similar to DeBaun et al. (2003),
in both patients tested. In a third study, Gicquel et al.
(2003) used a registry of 149 patients with BWS to
identify 6 patients with BWS born after ART. All six
tested positive for hypomethylation at LIT1. In addi-
tion, it is interesting (although not statistically signiﬁ-
cant) that one patient with BWS had been identiﬁed
earlier in a group of 91 children conceived from cry-
opreserved IVF embryos; molecular studies were not
performed (Sutcliffe et al. 1995). It is also interesting
to note that these studies identiﬁed patients with BWS
who were conceived by disparate ART methods, in-
cluding IVF, ICSI, and embryo cryopreservation, so
there does not appear to be an association between BWS
and a speciﬁc ART technique.
AS and ART
AS (reviewed by Clayton-Smith and Laan [2003]) is
caused by loss of function of the UBE3A gene on chro-
mosome 15, which is normally expressed from the ma-
ternal allele in the brain and encodes a ubiquitin protein
ligase (Scheffner et al. 1993). Although 10% of patients
with AS have point mutations involving the maternal
allele of UBE3A (Kishino et al. 1997; Matsuura et al.
1997), ∼70% of cases result from an interstitial deletion
of the maternal homologue of chromosome 15q11-13,
including UBE3A (Knoll et al. 1989). AS also arises
infrequently from paternal uniparental disomy for chro-
mosome 15 (Malcolm et al. 1991). In addition, ∼4% of
patients with AS have a maternally inherited microde-
letion of an imprinting control center (ICC) on 15q
(Buiting et al. 1995) or have epigenetic alterations to
this locus, involving aberrant hypomethylation of the
maternally inherited chromosome (Buiting et al. 1998).
The bipartite ICC lies proximal to the small nuclear
ribonucleoprotein polypeptide N (SNRPN) gene; this
ICC is normally methylated on the maternal allele. A
region 35 kb upstream of SNRPN exon 1 controls the
paternal-to-maternal imprint switch; maternally inher-
ited microdeletions disrupt the establishment of the ma-
ternal imprint and lead to AS. Similarly, a region around
exon 1 of SNRPN controls the maternal-to-paternal im-
print switch; paternally inherited microdeletions disrupt
the establishment of the paternal imprint and lead to a
related neurodevelopmental disorder, Prader-Willi syn-
drome. In patients with AS who have sporadic imprint-
ing defects, the maternal copy of the ICC is aberrantly
hypomethylated (Buiting et al. 1998).
Cox et al. (2002) identiﬁed two children with AS who
were conceived by ICSI, and Orstavik et al. (2003) iden-
tiﬁed another child with AS who was conceived by ICSI.
All three ICSI-conceived patients with AS showed hy-
pomethylation of the ICC proximal to SNRPN. FISH
studies and microsatellite analysis ruled out interstitial
deletions of chromosome 15q and uniparental disomy,
respectively. In addition, microdeletions within the ICC
were ruled out by Southern blot analysis. Thus, it was
concluded that all three children had sporadic imprint-
ing defects manifested as hypomethylation. This is par-
ticularly interesting, considering that the most common
cause of AS is deletion within 15q (70% of all cases),
whereas imprinting defects account for only 3% (at
most) of all cases.
It is striking that most (but not all) ART-associated
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defects in imprinting disorders involve the maternal al-
lele—for example, aberrant hypomethylation of the ma-
ternal LIT1 allele in BWS and aberrant hypomethyla-
tion of the maternal ICC in AS. Although this inference
admittedly is based on very limited data, it would sug-
gest that ART effects are greater on the oocyte than on
the sperm and are related either (1) to maturational or
environmental changes caused by ART or (2) to the
nature of reproductive problems affecting the oocyte
and are not caused by the procedure. Either way, a
mechanistic understanding would have profound con-
sequences both for reducing ART-related birth defects
and for reproductive success.
RB and ART
RB is a tumor of the retina that occurs in early childhood
and is the classic embryonal tumor used to conﬁrm to
the Knudson two-hit hypothesis of cancer. TheRB1 gene
on chromosome 13q14 was the ﬁrst tumor suppressor
identiﬁed. In most cases, RB arises from a mutation (ei-
ther inherited or sporadic) on one RB1 allele, with loss
of the other allele by chromosomal loss or deletion. Chil-
dren with bilateral disease have generally inherited a
germline mutation in RB1, whereas, in children with
unilateral disease, both RB1 alleles undergo somatic in-
activation. However, in some unilateral cases, the RB1
gene is epigenetically silenced, as indicated by hyper-
methylation of the promoter region and exon 1 (Greger
et al. 1989; Ohtani-Fujita et al. 1993) and reduced RB1
expression (Sakai et al. 1991). In addition, Ohtani-Fujita
et al. (1997) determined that the frequency of hyper-
methylation in unilateral tumors is 9% (13/140),
whereas the frequency was only 1% in hereditary bi-
lateral tumors (1/101). Thus, epigenetic mechanisms
clearly play a role in some patients with RB. Additional
evidence for epigenetic mechanisms involved in RB in-
cludes the observation of differential methylation of the
region of chromosome 13q around the RB1 gene (Blan-
quet et al. 1991) and the preferential loss of maternal
alleles in sporadic cases, suggesting latent or aberrant
imprinting in some individuals (Leach et al. 1990; Nau-
mova et al. 1994; Naumova and Sapienza 1994).
Moll et al. (2003) reported ﬁve cases of RB in children
conceived by IVF in the Netherlands. As in the studies
reporting BWS and AS in IVF-conceived children, these
cases were not ascertained through studies of an IVF
population; rather, they were ascertained from an oph-
thalmology clinic. The authors estimated that the in-
cidence of RB in the Netherlands is 1/17,000 live births.
They inferred a relative risk of 4.9 or 7.2 under the
alternative assumptions that 1.5% or 1.0% of all births
follow ART. Two of the affected children in their series
had bilateral disease, and, in one of these cases, a mu-
tation was identiﬁed. The remaining three cases had
unilateral disease, and no mutation could be identiﬁed.
Unfortunately, the authors did not report the status of
methylation or expression of the RB1 gene.
Insights from Ruminants
In the animal husbandry industry, there has been a long
history of reproductive technology, from sperm cryo-
preservation in the 1950s to a more recent rapid ex-
pansion of the use of ART, paralleling that in humans
(Thibier 1998). Studies of ruminants (cattle and sheep)
born after ART have documented the frequent appear-
ance of abnormally large calves and lambs, with an in-
crease of 8%–50% from mean control weight, at inci-
dences of up to 100% (reviewed by Young et al. [1998]).
This overgrowth is termed “large offspring syndrome”
(LOS) (reviewed by Sinclair et al. [2000]) and is char-
acterized by a signiﬁcant increase in birth weight, in-
creased gestational length, breathing problems at birth,
and increased frequency of perinatal death. LOS occurs
after embryo culture, transfer of embryos into an asyn-
chronous uterine environment (i.e., one in which ges-
tational age is unmatched between the embryo and the
recipient), or a maternal gestational diet high in urea.
LOS also occurs after nuclear transfer cloning, in which
cloned embryos are cultured in vitro and then are trans-
ferred into an asynchronous recipient.
Virtually all culture systems associated with LOS in-
volve exposure to sera or cocultured support cells, such
as granulosa cells, oviductal cells, or ﬁbroblasts (re-
viewed in Catt 1994). Thus, it is thought that growth
factors in the sera or secreted by the support cells may
be involved in the etiology of LOS. Important steps in
epigenetic reprogramming occur in germ cells and in the
early embryo.
There could also be an epigenetic explanation for
LOS following embryo culture. Young et al. (2001) re-
port a differentially methylated region (DMR) in intron
2 of the insulin-like growth factor II receptor gene
(IGF2R) in sheep, which is imprinted in mouse (Barlow
et al. 1991) and possibly variably imprinted in humans
(Xu et al. 1993). The IGF2R protein is a multifunctional
transmembrane receptor that binds mannose-6-phos-
phate residues on lysosomal enzymes and transports
them into lysosomes (Wang et al. 1994). IGF2R also
has a separate binding site for IGF2 (Kiess et al. 1988)
and is thought to act as a sink for IGF2 by transporting
it to lysosomes for degradation. Young et al. (2001)
used a model for LOS in which in vivo fertilized eggs
are cultured in vitro for 5 d. Young et al. recovered
fetuses after 125 d of gestation; 25% of cultured fetuses
(12/48) were abnormally large. They reported 30%–
60% reduction of IGF2R mRNA and protein in the
fetuses with LOS, and this difference was accompanied
by loss of methylation of the maternal IGF2R DMR.
Niemitz and Feinberg: Epigenetics and Assisted Reproductive Technology 605
In addition, experiments in mice provide direct evi-
dence for alterations of methylation patterns and birth
weight in cultured embryos. Khosla et al. (2001) deter-
mined that addition of serum to mouse embryos cul-
tured in M16 medium results in changes in expression
and methylation of the imprinted genes H19, Igf2,
Grb10, and Grb7 and reduction in fetal weight. Also,
Doherty et al. (2000) studied the effect of culture on
mouse H19 expression and methylation. They found
that the normally silent paternal allele was aberrantly
expressed and hypomethylated. These alterations were
dependent on the type of culture media used, with spec-
iﬁcity for culture inWhitten’s medium but not in KSOM
with amino acids. Although the authors did not address
this point, we hypothesize that the critical difference
may be methionine content, which can affect DNA
methylation and imprinting (Wolff et al. 1998; Water-
land and Jirtle 2003). In this regard, it is particularly
worrisome that many IVF clinics purchase media from
companies that do not divulge the formulation of the
media they market for human embryo culture. This se-
crecy is particularly worrisome, since embryos adapt to
imperfect media with unclear consequences on gene ex-
pression and long-term effects (Summers and Biggers
2003). It is remarkable that the U.S. Food and Drug
Administration (2001) regulates tissue-culture media
for human ex vivo use only for toxicity and sterility and
does not consider the effect of varying media on preg-
nancy outcome or birth defects.
A Call for Investigation
Two related questions call for investigation: (1) the re-
lationship, if any, between birth defects and ART and
(2) the overlapping but independent question of the re-
lationship between ART and epigenetic defects in the
resulting offspring.
Are Children Born after ART More Likely to Develop
Birth Defects?
A strong but circumstantial argument has been made
for an association between ART and some of the dis-
orders known to result from an epigenetic mechanism.
However, large prospective studies have not yet been
performed. A beginning step was taken by the Panel to
Evaluate the U.S. Standard Certiﬁcates and Reports,
which recommended that a question relating to fertility
treatment should be added to the U.S. Standard Certif-
icate of Live Birth (National Center for Health Statistics
2000). Information collected on standard certiﬁcates is
used to produce national vital statistics and is therefore
a critical source of population-based public health data.
Unfortunately, due to limited resources, implementation
of the revised certiﬁcate will be phased in state by state
over a number of years. Therefore, a complete national
data set of revised certiﬁcate items is not expected to be
available until the end of the present decade. Long-term
follow-up is also critical. For example, one of the most
troubling potential complications suggested by the stud-
ies of BWS and RB with ART is malignancy, and as-
certainment of cancer would necessitate multiyear fol-
low-up. A comprehensive evaluation of existing data on
the health and developmental outcomes of children born
after ART is underway, and the results of this study will
be valuable in lending support to this call for further
research and in suggesting study design and outcome
measures (Redfearn 2003).
Is ART Associated with Epigenetic Defects, and, If So,
What Is the Mechanism for This Association?
Determining the answer to this questionwould require
additional in-depth investigation, including laboratory
studies—in a limited population group in which parents
are asked to consent voluntarily to cord blood sampling
for epigenetic testing and to provide detailed clinical in-
formation. If the association of epigenetic alterations
with ART is conﬁrmed, there are two equally important
alternative explanations for it:
1. Epigenetic alterations could arise directly from
some aspect of ART. The most obvious mechanism is in
vitro culture itself, or the media used, but there are other
possibilities. For example, medically induced ovarian
hyperstimulation that precedes fertilization could be re-
sponsible, as could alterations in maturational timing of
the gametes that are harvested.
2. Epigenetic alterations could be a signiﬁcant cause
of infertility, rather than a consequence of the procedure
used to treat it. Thus, infertile couples using ART could
have an increased prevalence of epigenetic defects in
their gametes, which ART is simply uncovering. To ad-
dress this possibility, it is critical to ascertain in any study
design the underlying basis of infertility. If, for example,
epigenetic alterations are found only among those cou-
ples with ovarian failure or sperm maturational defects
and not among those with mechanical problems (e.g.,
tubal disease), then these changes are unlikely to be
caused by the procedure. Of course, uncovering an epi-
genetic cause for infertility would be a major advance
in and of itself.
Conclusion
An association between ART and epigenetic defects is
credible and is supported by experimental studies of
mouse embryo culture and by LOS in ruminants. How-
ever, conclusive demonstration of such an association
and identiﬁcation of its cause can only be accomplished
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by large-scale and long-term outcome studies, as well as
by laboratory research. In addition to their importance
for understanding the epigenetics of ART, such studies
may reveal common causes of birth defects that are mag-
niﬁed by ART. For example, if the methyl donor content
of media is critical to ART-mediated embryo anomalies,
this would suggest that dietary factors might play a sim-
ilar role in commonly occurring birth defects in non-
ART pregnancies. Furthermore, it is possible that ad-
ditional studies may reveal that epigenetic defects are a
mechanism for some causes of infertility, rather than a
consequence of ART. Such insights would represent an
important ﬁrst step in diagnosing and treating the un-
derlying causes of infertility, reducing the need and cost
of surgical treatment. Finally, although pregnancy rates
from ART have been reported to the Centers for Disease
Control, birth defects and cancer are not routinely as-
sessed, and neither is the relationship between speciﬁc
outcomes and media or procedural details. In this era
of heightened involvement of institutional review boards
in even minimally invasive research, it is surprising that
there is a relative lack of such surveillance in developing
methods for creating and culturing human embryos in-
tended for birth. Design of the studies we propose is a
complex question that itself requires further study and
discussion—hopefully in an appropriate forum and with
broad input from investigators, practitioners, and ethi-
cists to ensure appropriate study design and privacy
protection.
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